Patients with tricuspid regurgitation (TR) are rarely surgically treated1, are medically managed, and often experience debilitating symptoms. While the prevalence of TR and the associated mortality rates for severe TR are high2,3, limited treatment options exist.
The Edwards PASCAL transcatheter valve repair system adds to TMTT's portfolio of TR treatment options and is designed to treat both mitral and tricuspid regurgitation, improving patient symptoms and quality of life using the same device.
In early compassionate use exprience, the PASCAL repair system demonstrated high procedural success and significant clinical improvements in patients with challenging tricuspid anatomy and severe TR. In addition, favorable right ventricular remodling was observed at the 30-days follow-up.
Sign up now to receive event and news information from Edwards Lifesciences including:
Please update to a current version of your preferred browser, this site will perform effectively on the following:Unable to update your browser?
If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility